A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/22 (2006.01) A61K 9/20 (2006.01) A61K 31/455 (2006.01) C08J 3/075 (2006.01)
Patent
CA 2251816
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
L'invention se rapporte à des dosages galéniques solides, s'administrant par voie orale, à libération prolongée qui comprennent des particules agglomérées d'un médicament thérapeutiquement actif, de forme amorphe, un agent gélifiant, un agent renforçant la solidité du gel ionisable et un diluant inerte, ainsi qu'à des procédés de préparation et d'utilisation de ceux-ci. Ces dosages galéniques sont utilisés dans le traitement de l'hypertension chez l'homme.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Edward Mendell Co. Inc.
Penwest Pharmaceutical Co.
LandOfFree
Sustained release heterodisperse hydrogel systems -... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release heterodisperse hydrogel systems -..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release heterodisperse hydrogel systems -... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1642959